New framework proposes how to pick safer targets for senolytic immunotherapy
A proposed four-criteria framework for selecting senescence-associated antigens finds that neither uPAR nor GPNMB currently meets all requirements.
A proposed four-criteria framework for selecting senescence-associated antigens finds that neither uPAR nor GPNMB currently meets all requirements.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.